Edition:
United Kingdom

OncoMed Pharmaceuticals Inc (OMED.OQ)

OMED.OQ on NASDAQ Stock Exchange Global Select Market

0.93USD
10 Dec 2018
Change (% chg)

$-0.05 (-5.11%)
Prev Close
$0.98
Open
$0.95
Day's High
$1.00
Day's Low
$0.90
Volume
152,060
Avg. Vol
30,204
52-wk High
$5.07
52-wk Low
$0.90

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 19.52 0.159
Jun '18 6.87 -0.104
Mar '18 7.85 -0.146
FY 2017 Dec '17 20.64 0.220
Sep '17 5.11 -0.284
Jun '17 6.20 -0.405
Mar '17 6.21 -0.607
FY 2016 Dec '16 6.22 -0.602
Sep '16 5.92 -0.766
Jun '16 6.66 -0.914
Mar '16 6.35 -0.900
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 3 7.34 11.82 4.00 5.40
Quarter Ending Mar-19 1 6.20 6.20 6.20 5.01
Year Ending Dec-18 3 41.43 46.06 38.24 23.87
Year Ending Dec-19 3 33.95 42.30 25.00 31.58
Earnings (per share)
Quarter Ending Dec-18 2 -0.14 -0.07 -0.22 -0.37
Year Ending Dec-18 3 -0.49 -0.16 -0.99 -1.44
Year Ending Dec-19 3 -0.95 -0.41 -1.53 -0.90
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 92.25 33.63
P/E High - Last 5 Yrs. -- 323.36 45.43
P/E Low - Last 5 Yrs. -- 90.29 24.43
Beta 2.74 0.91 0.90
Price to Sales (TTM) 6.68 116.41 5.77
Price to Book (MRQ) -- 15.60 5.12
Price to Tangible Book (MRQ) -- 14.89 6.54
Price to Cash Flow (TTM) -- 72.75 23.57
% Owned Institutions 73.35 12.59 1.83

Dividends

  Company industry sector
Dividend Yield -- 0.39 1.49
Dividend Yield - 5 Year Avg -- 0.31 1.50
Dividend 5 Year Growth Rate -- 2.65 5.08
Payout Ratio(TTM) -- 23.68 43.75

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -7.07 358.89 7.43
Sales (TTM) vs TTM 1 Yr. Ago 0.01 90.38 5.80
Sales - 5 Yr. Growth Rate -4.35 31.32 10.19
EPS (MRQ) vs Qtr. 1 Yr. Ago 48.37 36.71 21.03
EPS (TTM) vs TTM 1 Yr. Ago 28.37 -- --
EPS - 5 Yr. Growth Rate -- 39.68 10.79
Capital Spending - 5 Yr. Growth Rate -12.42 39.59 15.12

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.98 2.28
Current Ratio (MRQ) 3.39 5.42 3.11
LT Debt to Equity (MRQ) -- 33.58 11.47
Total Debt to Equity (MRQ) -- 35.41 15.63
Interest Coverage (TTM) -- -152.89 31.38

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 41.87 54.21
Gross Margin - 5 Yr. Avg. -- 49.14 51.98
EBITD Margin (TTM) -335.43 -- --
EBITD - 5 Yr. Avg -181.75 -506.71 11.83
Operating Margin (TTM) -352.49 -728.63 4.90
Operating Margin - 5 Yr. Avg. -186.73 -526.19 7.44
Pre-Tax Margin (TTM) -350.45 -694.90 5.91
Pre-Tax Margin - 5 Yr. Avg. -186.42 -531.06 7.89
Net Profit Margin (TTM) -350.52 -696.67 2.16
Net Profit Margin - 5 Yr. Avg. -187.38 -534.50 4.12
Effective Tax Rate (TTM) -- 25.12 23.36
Effective Tax Rate - 5 Yr. Avg. -- 20.63 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) 201,188 25,687,363 898,926,015
Net Income/Employee (TTM) -705,205 2,194,067 106,550,787
Receivable Turnover (TTM) 12.24 18.46 5.94
Inventory Turnover (TTM) -- 2.61 3.62
Asset Turnover (TTM) 0.15 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -53.56 -1.11 11.50
Return on Assets - 5 Yr. Avg. -27.30 2.88 12.67
Return on Investment (TTM) -75.79 0.28 15.02
Return on Investment - 5 Yr. Avg. -34.15 1.84 16.45
Return on Equity (TTM) -- 0.94 16.60
Return on Equity - 5 Yr. Avg. -- 2.30 17.56
  1 Year 3 Year 5 Year
Sales % -2.88 -12.68 -4.35
EPS (TTM) % -10.32 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for OncoMed Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -3.11 -6.45 57 57
13 Week 27.49 21.28 99 62
26 Week -50.23 -54.01 21 81
52 Week -61.28 -67.18 25 47
YTD -43.45 -50.34 29 60
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 64.87%
# of Holders: 72
Total Shares Held: 25,059,603
3 Mo. Net Change: -428,833
# New Positions: 9
# Closed Positions: 19
# Increased Positions: 26
# Reduced Positions: 34
# Net Buyers: -8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.